Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML
Yilmaz, Musa, Alfayez, Mansour, DiNardo, Courtney D, Borthakur, Gautam, Kadia, Tapan M, Konopleva, Marina Y, Loghavi, Sanam, Kanagal-Shamanna, Rashmi, Patel, Keyur P, Jabbour, Elias J, Garcia-Manero, Guillermo, Pemmaraju, Naveen, Pierce, Sherry A, Ghayas, Issa, Short, Nicholas J, Montalban-Bravo, Guillermo, Takahashi, Koichi, Assi, Rita, Alotaibi, Ahmad S, Ohanian, Maro, Andreeff, Michael, Cortes, Jorge E, Kantarjian, Hagop M, Ravandi, Farhad, Daver, Naval G
Published in Journal of hematology and oncology (08.10.2020)
Published in Journal of hematology and oncology (08.10.2020)
Get full text
Journal Article
High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia
Zeng, Zhihong, Liu, Wenbin, Tsao, Twee, Qiu, YiHua, Zhao, Yang, Samudio, Ismael, Sarbassov, Dos D, Kornblau, Steven M, Baggerly, Keith A, Kantarjian, Hagop M, Konopleva, Marina, Andreeff, Michael
Published in Haematologica (Roma) (01.09.2017)
Published in Haematologica (Roma) (01.09.2017)
Get full text
Journal Article
Effects of bosutinib treatment on renal function in patients with Philadelphia chromosome-positive leukemias
Cortes, Jorge E., MD, Gambacorti-Passerini, Carlo, MD, Kim, Dong-Wook, MD, PhD, Kantarjian, Hagop M., MD, Lipton, Jeff H., MD, PhD, FRCPC, Lahoti, Amit, MD, Talpaz, Moshe, MD, Matczak, Ewa, MD, Barry, Elly, MD, Leip, Eric, PhD, Brümmendorf, Tim H., MD, Khoury, H. Jean, MD, FACP
Published in Clinical lymphoma, myeloma and leukemia (01.10.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2017)
Get full text
Journal Article
Phase I-II Study of Oxaliplatin, Fludarabine, Cytarabine, and Rituximab Combination Therapy in Patients With Richter's Syndrome or Fludarabine-Refractory Chronic Lymphocytic Leukemia
TSIMBERIDOU, Apostolia M, WIERDA, William G, KIPPS, Thomas J, BROWN, Jennifer R, FIORENTINO, Albert, LERNER, Susan, KANTARJIAN, Hagop M, KEATING, Michael J, PLUNKETT, William, KURZROCK, Razelle, O'BRIEN, Susan, WEN, Sijin, FERRAJOLI, Alessandra, RAVANDI-KASHANI, Farhad, GARCIA-MANERO, Guillermo, ESTROV, Zeev
Published in Journal of clinical oncology (10.01.2008)
Published in Journal of clinical oncology (10.01.2008)
Get full text
Journal Article
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms
Chien, Kelly S., Ong, Faustine, Kim, Kunhwa, Li, Ziyi, Kanagal‐Shamanna, Rashmi, DiNardo, Courtney D., Takahashi, Koichi, Montalban‐Bravo, Guillermo, Hammond, Danielle, Sasaki, Koji, Pierce, Sherry A., Kantarjian, Hagop M., Garcia‐Manero, Guillermo
Published in Cancer medicine (Malden, MA) (01.03.2024)
Published in Cancer medicine (Malden, MA) (01.03.2024)
Get full text
Journal Article
Significance of Increasing Levels of Minimal Residual Disease in Patients With Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia in Complete Cytogenetic Response
Kantarjian, Hagop M, Shan, Jianqin, Jones, Daniel, O'Brien, Susan, Rios, Mary Beth, Jabbour, Elias, Cortes, Jorge
Published in Journal of clinical oncology (01.08.2009)
Published in Journal of clinical oncology (01.08.2009)
Get full text
Journal Article
Dorsal column myelopathy after intrathecal chemotherapy for leukemia
Pinnix, Chelsea C., Chi, Linda, Jabbour, Elias J., Milgrom, Sarah A., Smith, Grace L., Daver, Naval, Garg, Naveen, Cykowski, Matthew D., Fuller, Greg, Cachia, David, Kamiya-Matsuoka, Carlos, Woodman, Karin, Dinardo, Courtney, Jain, Nitin, Kadia, Tapan M., Pemmaraju, Naveen, Ohanian, Maro, Konopleva, Marina, Kantarjian, Hagop M., Dabaja, Bouthaina S.
Published in American journal of hematology (01.02.2017)
Published in American journal of hematology (01.02.2017)
Get full text
Journal Article
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents
Hammond, Danielle, Loghavi, Sanam, Wang, Sa A., Konopleva, Marina Y., Kadia, Tapan M., Daver, Naval G., Ohanian, Maro, Issa, Ghayas C., Alvarado, Yesid, Short, Nicholas J., Sasaki, Koji, Pemmaraju, Naveen, Montalban-Bravo, Guillermo, Lachowiez, Curtis A., Maiti, Abhishek, Garcia-Manero, Guillermo, Jabbour, Elias J., Borthakur, Gautam, Ravandi, Farhad, Takahashi, Koichi, Pierce, Sherry R., Kantarjian, Hagop M., DiNardo, Courtney D.
Published in Blood cancer journal (New York) (21.09.2023)
Published in Blood cancer journal (New York) (21.09.2023)
Get full text
Journal Article
Important Therapeutic Targets in Chronic Myelogenous Leukemia
KANTARJIAN, Hagop M, GILES, Francis, QUINTAS-CARDAMA, Alfonso, CORTES, Jorge
Published in Clinical cancer research (15.02.2007)
Published in Clinical cancer research (15.02.2007)
Get full text
Journal Article
Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia
Yamazaki, Jumpei, Taby, Rodolphe, Jelinek, Jaroslav, Raynal, Noel J M, Cesaroni, Matteo, Pierce, Sherry A, Kornblau, Steven M, Bueso-Ramos, Carlos E, Ravandi, Farhad, Kantarjian, Hagop M, Issa, Jean-Pierre J
Published in JNCI : Journal of the National Cancer Institute (01.02.2016)
Published in JNCI : Journal of the National Cancer Institute (01.02.2016)
Get full text
Journal Article
Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia
Ravandi, Farhad, Ritchie, Ellen K, Sayar, Hamid, Lancet, Jeffrey E, Craig, Michael D, Vey, Norbert, Strickland, Stephen A, Schiller, Gary J, Jabbour, Elias, Pigneux, Arnaud, Horst, Heinz-August, Récher, Christian, Klimek, Virginia M, Cortes, Jorge E, Carella, Angelo-Michele, Egyed, Miklos, Krug, Utz, Fox, Judith A, Craig, Adam R, Ward, Renee, Smith, Jennifer A, Acton, Gary, Kantarjian, Hagop M, Stuart, Robert K
Published in Haematologica (Roma) (01.11.2018)
Published in Haematologica (Roma) (01.11.2018)
Get full text
Journal Article
Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab
Kantarjian, Hagop M., Logan, Aaron C., Zaman, Faraz, Gökbuget, Nicola, Bargou, Ralf C., Zeng, Yi, Zugmaier, Gerhard, Locatelli, Franco
Published in Therapeutic Advances in Hematology (01.01.2023)
Published in Therapeutic Advances in Hematology (01.01.2023)
Get full text
Book Review
Journal Article
The importance of greater speed in drug development for advanced malignancies
Stewart, David J., Stewart, Andrew A., Wheatley‐Price, Paul, Batist, Gerald, Kantarjian, Hagop M., Schiller, Joan, Clemons, Mark, Bradford, John‐Peter, Gillespie, Laurel, Kurzrock, Razelle
Published in Cancer medicine (Malden, MA) (01.05.2018)
Published in Cancer medicine (Malden, MA) (01.05.2018)
Get full text
Journal Article
Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B‐lymphoblastic leukemia in the era of tyrosine kinase inhibitors
Jaso, Jesse, Thomas, Deborah A., Cunningham, Krista, Jorgensen, Jeffrey L., Kantarjian, Hagop M., Medeiros, L. Jeffrey, Wang, Sa A.
Published in Cancer (01.09.2011)
Published in Cancer (01.09.2011)
Get full text
Journal Article
Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
Masarova, Lucia, Yin, C Cameron, Cortes, Jorge E, Konopleva, Marina, Borthakur, Gautam, Newberry, Kate J, Kantarjian, Hagop M, Bueso-Ramos, Carlos E, Verstovsek, Srdan
Published in Experimental hematology & oncology (09.11.2017)
Published in Experimental hematology & oncology (09.11.2017)
Get full text
Journal Article